Globus Medical Reports Third Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Globus Medical (GMED) PT Raised to $80 at BofA Securities
November 6, 2024 5:57 AM ESTBofA Securities analyst Craig Bijou raised the price target on Globus Medical (NYSE: GMED) to $80.00 (from $55.00) while maintaining a Underperform rating.
The analyst comments "GMED continues to deliver beat and raises showing that it has managed the NuVasive integration better than... More
Globus Medical (GMED) Tops Q3 EPS by 18c
November 5, 2024 4:24 PM ESTGlobus Medical (NYSE: GMED) reported Q3 EPS of $0.83, $0.18 better than the analyst estimate of $0.65. Revenue for the quarter came in at $625.7 million versus the consensus estimate of $604.71 million.
GUIDANCE:
Globus Medical sees FY2024 EPS of $2.90-$3.00, versus the consensus of... More
